Scorpion Therapeutics Stock
HealthTechLooking to sell Scorpion Therapeutics stock or options?
Scorpion Therapeutics is a precision therapeutics company focused on developing cancer treatments. By integrating advanced technologies in target discovery, medicinal chemistry, and translational medicine, they create a pipeline of targeted small-molecule drugs designed to surpass the limitations of current treatments. This fit-to-purpose model aims to efficiently advance the next wave of precision oncology, allowing healthcare professionals to offer patients innovative therapies.
Omega Funds, Mass General Brigham Ventures, Nextech Invest, Abingworth, Willett Advisors, Atlas Venture, Olive Tree Capital, Citadel Enterprise Americas, Frazier Healthcare Partners, Boxer Capital, Fidelity Management & Research Company, Surveyor Capital, OrbiMed, Casdin Capital, The Invus Group, Revelation Partners, Vida Ventures (Boston), Hillhouse Investment Group, EcoR1 Capital, Logos Capital, Woodline Partners, Avoro Capital, Mass General Brigham Innovation, Janus Henderson Investors, Wellington Management.